Global Topical Contraceptive Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Nov-2022
No. of pages: 100
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Topical Contraceptive manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Topical Contraceptive market. Further, it explains the major drivers and regional dynamics of the global Topical Contraceptive market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Allergan

- Okamoto Industries

- Reckitt Benckiser

- Agile Therapeutics

- Bayer Pharma

- Ferring Pharmaceuticals

- HLL Lifecare

- Lupin Pharmaceuticals

- Mayer Laboratories

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Topical Contraceptive Segment by Type

- Topical Contraceptive Suppository

- Topical Contraceptive Film

- Topical Contraceptive Pill

- Others

Topical Contraceptive Segment by Application

- Online Stores

- Retail Stores

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Topical Contraceptive market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Topical Contraceptive, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Topical Contraceptive, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Topical Contraceptive, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Topical Contraceptive sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Topical Contraceptive market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Topical Contraceptive sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Allergan, Okamoto Industries, Reckitt Benckiser, Agile Therapeutics, Bayer Pharma, Ferring Pharmaceuticals, HLL Lifecare, Lupin Pharmaceuticals and Mayer Laboratories, etc.

Global Topical Contraceptive Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Topical Contraceptive Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Topical Contraceptive Suppository
1.2.3 Topical Contraceptive Film
1.2.4 Topical Contraceptive Pill
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Topical Contraceptive Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Online Stores
1.3.3 Retail Stores
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Topical Contraceptive Market Size (2017-2028)
2.1.1 Global Topical Contraceptive Revenue (2017-2028)
2.1.2 Global Topical Contraceptive Sales (2017-2028)
2.2 Global Topical Contraceptive Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Topical Contraceptive Sales by Regions (2017-2022)
2.2.2 Global Topical Contraceptive Revenue by Regions (2017-2022)
2.3 Global Topical Contraceptive Market Size Forecast by Region
2.3.1 Global Topical Contraceptive Sales Forecast by Region (2023-2028)
2.3.2 Global Topical Contraceptive Revenue Forecast by Region (2023-2028)
2.4 Global Top Topical Contraceptive Regions (Countries) Ranking by Market Size
2.5 Topical Contraceptive Market Dynamics
2.5.1 Topical Contraceptive Market Trends
2.5.2 Topical Contraceptive Market Drivers
2.5.3 Topical Contraceptive Market Challenges
2.5.4 Topical Contraceptive Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Topical Contraceptive Manufacturers by Sales (2017-2022)
3.1.1 Global Topical Contraceptive Sales by Manufacturers (2017-2022)
3.1.2 Global Topical Contraceptive Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Topical Contraceptive Sales in 2021
3.2 Global Top Manufacturers Topical Contraceptive by Revenue
3.2.1 Global Topical Contraceptive Revenue by Manufacturers (2017-2022)
3.2.2 Top Topical Contraceptive Manufacturers Covered: Ranking by Revenue
3.2.3 Global Topical Contraceptive Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Topical Contraceptive Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Contraceptive as of 2021)
3.4 Global Topical Contraceptive Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Topical Contraceptive Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Topical Contraceptive Market
3.7 Key Manufacturers Topical Contraceptive Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Topical Contraceptive Market Size by Type
4.1 Global Topical Contraceptive Historic Market Review by Type (2017-2022)
4.1.1 Global Topical Contraceptive Sales Market Share by Type (2017-2022)
4.1.2 Global Topical Contraceptive Revenue Market Share by Type (2017-2022)
4.1.3 Topical Contraceptive Price by Type (2017-2022)
4.2 Global Topical Contraceptive Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Topical Contraceptive Sales Forecast by Type (2023-2028)
4.2.2 Global Topical Contraceptive Revenue Forecast by Type (2023-2028)
4.2.3 Topical Contraceptive Price Forecast by Type (2023-2028)
5 Global Topical Contraceptive Market Size by Application
5.1 Global Topical Contraceptive Historic Market Review by Application (2017-2022)
5.1.1 Global Topical Contraceptive Sales Market Share by Application (2017-2022)
5.1.2 Global Topical Contraceptive Revenue Market Share by Application (2017-2022)
5.1.3 Topical Contraceptive Price by Application (2017-2022)
5.2 Global Topical Contraceptive Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Topical Contraceptive Sales Forecast by Application (2023-2028)
5.2.2 Global Topical Contraceptive Revenue Forecast by Application (2023-2028)
5.2.3 Topical Contraceptive Price Forecast by Application (2023-2028)
6 North America
6.1 North America Topical Contraceptive Sales Breakdown by Company
6.1.1 North America Topical Contraceptive Sales by Company (2017-2022)
6.1.2 North America Topical Contraceptive Revenue by Company (2017-2022)
6.2 North America Topical Contraceptive Market Size by Type
6.2.1 North America Topical Contraceptive Sales by Type (2017-2028)
6.2.2 North America Topical Contraceptive Revenue by Type (2017-2028)
6.3 North America Topical Contraceptive Market Size by Application
6.3.1 North America Topical Contraceptive Sales by Application (2017-2028)
6.3.2 North America Topical Contraceptive Revenue by Application (2017-2028)
6.4 North America Topical Contraceptive Market Size by Country
6.4.1 North America Topical Contraceptive Sales by Country (2017-2028)
6.4.2 North America Topical Contraceptive Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Topical Contraceptive Sales Breakdown by Company
7.1.1 Europe Topical Contraceptive Sales by Company (2017-2022)
7.1.2 Europe Topical Contraceptive Revenue by Company (2017-2022)
7.2 Europe Topical Contraceptive Market Size by Type
7.2.1 Europe Topical Contraceptive Sales by Type (2017-2028)
7.2.2 Europe Topical Contraceptive Revenue by Type (2017-2028)
7.3 Europe Topical Contraceptive Market Size by Application
7.3.1 Europe Topical Contraceptive Sales by Application (2017-2028)
7.3.2 Europe Topical Contraceptive Revenue by Application (2017-2028)
7.4 Europe Topical Contraceptive Market Size by Country
7.4.1 Europe Topical Contraceptive Sales by Country (2017-2028)
7.4.2 Europe Topical Contraceptive Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Topical Contraceptive Sales Breakdown by Company
8.1.1 Asia Pacific Topical Contraceptive Sales by Company (2017-2022)
8.1.2 Asia Pacific Topical Contraceptive Revenue by Company (2017-2022)
8.2 Asia Pacific Topical Contraceptive Market Size by Type
8.2.1 Asia Pacific Topical Contraceptive Sales by Type (2017-2028)
8.2.2 Asia Pacific Topical Contraceptive Revenue by Type (2017-2028)
8.3 Asia Pacific Topical Contraceptive Market Size by Application
8.3.1 Asia Pacific Topical Contraceptive Sales by Application (2017-2028)
8.3.2 Asia Pacific Topical Contraceptive Revenue by Application (2017-2028)
8.4 Asia Pacific Topical Contraceptive Market Size by Region
8.4.1 Asia Pacific Topical Contraceptive Sales by Region
8.4.2 Asia Pacific Topical Contraceptive Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Topical Contraceptive Sales Breakdown by Company
9.1.1 Latin America Topical Contraceptive Sales by Company (2017-2022)
9.1.2 Latin America Topical Contraceptive Revenue by Company (2017-2022)
9.2 Latin America Topical Contraceptive Market Size by Type
9.2.1 Latin America Topical Contraceptive Sales by Type (2017-2028)
9.2.2 Latin America Topical Contraceptive Revenue by Type (2017-2028)
9.3 Latin America Topical Contraceptive Market Size by Application
9.3.1 Latin America Topical Contraceptive Sales by Application (2017-2028)
9.3.2 Latin America Topical Contraceptive Revenue by Application (2017-2028)
9.4 Latin America Topical Contraceptive Market Size by Country
9.4.1 Latin America Topical Contraceptive Sales by Country (2017-2028)
9.4.2 Latin America Topical Contraceptive Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Topical Contraceptive Sales Breakdown by Company
10.1.1 Middle East and Africa Topical Contraceptive Sales by Company (2017-2022)
10.1.2 Middle East and Africa Topical Contraceptive Revenue by Company (2017-2022)
10.2 Middle East and Africa Topical Contraceptive Market Size by Type
10.2.1 Middle East and Africa Topical Contraceptive Sales by Type (2017-2028)
10.2.2 Middle East and Africa Topical Contraceptive Revenue by Type (2017-2028)
10.3 Middle East and Africa Topical Contraceptive Market Size by Application
10.3.1 Middle East and Africa Topical Contraceptive Sales by Application (2017-2028)
10.3.2 Middle East and Africa Topical Contraceptive Revenue by Application (2017-2028)
10.4 Middle East and Africa Topical Contraceptive Market Size by Country
10.4.1 Middle East and Africa Topical Contraceptive Sales by Country (2017-2028)
10.4.2 Middle East and Africa Topical Contraceptive Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Allergan Topical Contraceptive Products and Services
11.1.5 Allergan Topical Contraceptive SWOT Analysis
11.1.6 Allergan Recent Developments
11.2 Okamoto Industries
11.2.1 Okamoto Industries Corporation Information
11.2.2 Okamoto Industries Overview
11.2.3 Okamoto Industries Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Okamoto Industries Topical Contraceptive Products and Services
11.2.5 Okamoto Industries Topical Contraceptive SWOT Analysis
11.2.6 Okamoto Industries Recent Developments
11.3 Reckitt Benckiser
11.3.1 Reckitt Benckiser Corporation Information
11.3.2 Reckitt Benckiser Overview
11.3.3 Reckitt Benckiser Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Reckitt Benckiser Topical Contraceptive Products and Services
11.3.5 Reckitt Benckiser Topical Contraceptive SWOT Analysis
11.3.6 Reckitt Benckiser Recent Developments
11.4 Agile Therapeutics
11.4.1 Agile Therapeutics Corporation Information
11.4.2 Agile Therapeutics Overview
11.4.3 Agile Therapeutics Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Agile Therapeutics Topical Contraceptive Products and Services
11.4.5 Agile Therapeutics Topical Contraceptive SWOT Analysis
11.4.6 Agile Therapeutics Recent Developments
11.5 Bayer Pharma
11.5.1 Bayer Pharma Corporation Information
11.5.2 Bayer Pharma Overview
11.5.3 Bayer Pharma Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Bayer Pharma Topical Contraceptive Products and Services
11.5.5 Bayer Pharma Topical Contraceptive SWOT Analysis
11.5.6 Bayer Pharma Recent Developments
11.6 Ferring Pharmaceuticals
11.6.1 Ferring Pharmaceuticals Corporation Information
11.6.2 Ferring Pharmaceuticals Overview
11.6.3 Ferring Pharmaceuticals Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Ferring Pharmaceuticals Topical Contraceptive Products and Services
11.6.5 Ferring Pharmaceuticals Topical Contraceptive SWOT Analysis
11.6.6 Ferring Pharmaceuticals Recent Developments
11.7 HLL Lifecare
11.7.1 HLL Lifecare Corporation Information
11.7.2 HLL Lifecare Overview
11.7.3 HLL Lifecare Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 HLL Lifecare Topical Contraceptive Products and Services
11.7.5 HLL Lifecare Topical Contraceptive SWOT Analysis
11.7.6 HLL Lifecare Recent Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Overview
11.8.3 Lupin Pharmaceuticals Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Lupin Pharmaceuticals Topical Contraceptive Products and Services
11.8.5 Lupin Pharmaceuticals Topical Contraceptive SWOT Analysis
11.8.6 Lupin Pharmaceuticals Recent Developments
11.9 Mayer Laboratories
11.9.1 Mayer Laboratories Corporation Information
11.9.2 Mayer Laboratories Overview
11.9.3 Mayer Laboratories Topical Contraceptive Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Mayer Laboratories Topical Contraceptive Products and Services
11.9.5 Mayer Laboratories Topical Contraceptive SWOT Analysis
11.9.6 Mayer Laboratories Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Topical Contraceptive Value Chain Analysis
12.2 Topical Contraceptive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Topical Contraceptive Production Mode & Process
12.4 Topical Contraceptive Sales and Marketing
12.4.1 Topical Contraceptive Sales Channels
12.4.2 Topical Contraceptive Distributors
12.5 Topical Contraceptive Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Topical Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Topical Contraceptive Suppository
Table 3. Major Manufacturers of Topical Contraceptive Film
Table 4. Major Manufacturers of Topical Contraceptive Pill
Table 5. Major Manufacturers of Others
Table 6. Global Topical Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Topical Contraceptive Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Topical Contraceptive Sales by Region (2017-2022) & (K Units)
Table 9. Global Topical Contraceptive Sales Market Share by Region (2017-2022)
Table 10. Global Topical Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Topical Contraceptive Revenue Market Share by Region (2017-2022)
Table 12. Global Topical Contraceptive Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Topical Contraceptive Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Topical Contraceptive Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Topical Contraceptive Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Topical Contraceptive Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Topical Contraceptive Market Trends
Table 18. Topical Contraceptive Market Drivers
Table 19. Topical Contraceptive Market Challenges
Table 20. Topical Contraceptive Market Restraints
Table 21. Global Topical Contraceptive Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Topical Contraceptive Sales Share by Manufacturers (2017-2022)
Table 23. Global Topical Contraceptive Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Topical Contraceptive Manufacturers by Revenue (US$ Million) in 2021
Table 25. Topical Contraceptive Revenue Share by Manufacturers (2017-2022)
Table 26. Global Topical Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Contraceptive as of 2021)
Table 28. Key Manufacturers Topical Contraceptive Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Topical Contraceptive Plants/Factories Distribution
Table 30. Key Manufacturers Topical Contraceptive Area Served
Table 31. Date of Key Manufacturers Enter into Topical Contraceptive Market
Table 32. Key Manufacturers Topical Contraceptive Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Topical Contraceptive Sales (K Units) by Type (2017-2022)
Table 35. Global Topical Contraceptive Sales Share by Type (2017-2022)
Table 36. Global Topical Contraceptive Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Topical Contraceptive Price (K Units) by Type (2017-2022)
Table 38. Global Topical Contraceptive Sales (K Units) by Type (2023-2028)
Table 39. Global Topical Contraceptive Sales Share by Type (2023-2028)
Table 40. Global Topical Contraceptive Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Topical Contraceptive Revenue Share by Type (2023-2028)
Table 42. Global Topical Contraceptive Price (K Units) by Type (2023-2028)
Table 43. Global Topical Contraceptive Sales (K Units) by Application (2017-2022)
Table 44. Global Topical Contraceptive Sales Share by Application (2017-2022)
Table 45. Global Topical Contraceptive Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Topical Contraceptive Price (K Units) by Application (2017-2022)
Table 47. Global Topical Contraceptive Sales (K Units) by Application (2023-2028)
Table 48. Global Topical Contraceptive Sales Share by Application (2023-2028)
Table 49. Global Topical Contraceptive Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Topical Contraceptive Revenue Share by Application (2023-2028)
Table 51. Global Topical Contraceptive Price (K Units) by Application (2023-2028)
Table 52. North America Topical Contraceptive Sales by Company (2017-2022) & (K Units)
Table 53. North America Topical Contraceptive Sales Market Share by Company (2017-2022)
Table 54. North America Topical Contraceptive Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Topical Contraceptive Revenue Market Share by Company (2017-2022)
Table 56. North America Topical Contraceptive Sales by Type (2017-2022) & (K Units)
Table 57. North America Topical Contraceptive Sales by Type (2023-2028) & (K Units)
Table 58. North America Topical Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Topical Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Topical Contraceptive Sales by Application (2017-2022) & (K Units)
Table 61. North America Topical Contraceptive Sales by Application (2023-2028) & (K Units)
Table 62. North America Topical Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Topical Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Topical Contraceptive Sales by Country (2017-2022) & (K Units)
Table 65. North America Topical Contraceptive Sales by Country (2023-2028) & (K Units)
Table 66. North America Topical Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Topical Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Topical Contraceptive Sales by Company (2017-2022) & (K Units)
Table 69. Europe Topical Contraceptive Sales Market Share by Company (2017-2022)
Table 70. Europe Topical Contraceptive Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Topical Contraceptive Revenue Market Share by Company (2017-2022)
Table 72. Europe Topical Contraceptive Sales by Type (2017-2022) & (K Units)
Table 73. Europe Topical Contraceptive Sales by Type (2023-2028) & (K Units)
Table 74. Europe Topical Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Topical Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Topical Contraceptive Sales by Application (2017-2022) & (K Units)
Table 77. Europe Topical Contraceptive Sales by Application (2023-2028) & (K Units)
Table 78. Europe Topical Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Topical Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Topical Contraceptive Sales by Country (2017-2022) & (K Units)
Table 81. Europe Topical Contraceptive Sales by Country (2023-2028) & (K Units)
Table 82. Europe Topical Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Topical Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Topical Contraceptive Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Topical Contraceptive Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Topical Contraceptive Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Topical Contraceptive Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Topical Contraceptive Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Topical Contraceptive Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Topical Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Topical Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Topical Contraceptive Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Topical Contraceptive Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Topical Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Topical Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Topical Contraceptive Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Topical Contraceptive Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Topical Contraceptive Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Topical Contraceptive Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Topical Contraceptive Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Topical Contraceptive Sales Market Share by Company (2017-2022)
Table 102. Latin America Topical Contraceptive Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Topical Contraceptive Revenue Market Share by Company (2017-2022)
Table 104. Latin America Topical Contraceptive Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Topical Contraceptive Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Topical Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Topical Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Topical Contraceptive Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Topical Contraceptive Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Topical Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Topical Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Topical Contraceptive Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Topical Contraceptive Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Topical Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Topical Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Topical Contraceptive Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Topical Contraceptive Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Topical Contraceptive Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Topical Contraceptive Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Topical Contraceptive Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Topical Contraceptive Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Topical Contraceptive Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Topical Contraceptive Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Topical Contraceptive Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Topical Contraceptive Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Topical Contraceptive Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Topical Contraceptive Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Topical Contraceptive Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Topical Contraceptive Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Topical Contraceptive Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Topical Contraceptive Revenue by Country (2023-2028) & (US$ Million)
Table 132. Allergan Corporation Information
Table 133. Allergan Description and Overview
Table 134. Allergan Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. Allergan Topical Contraceptive Product and Services
Table 136. Allergan Topical Contraceptive SWOT Analysis
Table 137. Allergan Recent Developments
Table 138. Okamoto Industries Corporation Information
Table 139. Okamoto Industries Description and Overview
Table 140. Okamoto Industries Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Okamoto Industries Topical Contraceptive Product and Services
Table 142. Okamoto Industries Topical Contraceptive SWOT Analysis
Table 143. Okamoto Industries Recent Developments
Table 144. Reckitt Benckiser Corporation Information
Table 145. Reckitt Benckiser Description and Overview
Table 146. Reckitt Benckiser Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Reckitt Benckiser Topical Contraceptive Product and Services
Table 148. Reckitt Benckiser Topical Contraceptive SWOT Analysis
Table 149. Reckitt Benckiser Recent Developments
Table 150. Agile Therapeutics Corporation Information
Table 151. Agile Therapeutics Description and Overview
Table 152. Agile Therapeutics Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. Agile Therapeutics Topical Contraceptive Product and Services
Table 154. Agile Therapeutics Topical Contraceptive SWOT Analysis
Table 155. Agile Therapeutics Recent Developments
Table 156. Bayer Pharma Corporation Information
Table 157. Bayer Pharma Description and Overview
Table 158. Bayer Pharma Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 159. Bayer Pharma Topical Contraceptive Product and Services
Table 160. Bayer Pharma Topical Contraceptive SWOT Analysis
Table 161. Bayer Pharma Recent Developments
Table 162. Ferring Pharmaceuticals Corporation Information
Table 163. Ferring Pharmaceuticals Description and Overview
Table 164. Ferring Pharmaceuticals Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 165. Ferring Pharmaceuticals Topical Contraceptive Product and Services
Table 166. Ferring Pharmaceuticals Topical Contraceptive SWOT Analysis
Table 167. Ferring Pharmaceuticals Recent Developments
Table 168. HLL Lifecare Corporation Information
Table 169. HLL Lifecare Description and Overview
Table 170. HLL Lifecare Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 171. HLL Lifecare Topical Contraceptive Product and Services
Table 172. HLL Lifecare Topical Contraceptive SWOT Analysis
Table 173. HLL Lifecare Recent Developments
Table 174. Lupin Pharmaceuticals Corporation Information
Table 175. Lupin Pharmaceuticals Description and Overview
Table 176. Lupin Pharmaceuticals Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 177. Lupin Pharmaceuticals Topical Contraceptive Product and Services
Table 178. Lupin Pharmaceuticals Topical Contraceptive SWOT Analysis
Table 179. Lupin Pharmaceuticals Recent Developments
Table 180. Mayer Laboratories Corporation Information
Table 181. Mayer Laboratories Description and Overview
Table 182. Mayer Laboratories Topical Contraceptive Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 183. Mayer Laboratories Topical Contraceptive Product and Services
Table 184. Mayer Laboratories Topical Contraceptive SWOT Analysis
Table 185. Mayer Laboratories Recent Developments
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Topical Contraceptive Distributors List
Table 189. Topical Contraceptive Customers List
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Topical Contraceptive Product Picture
Figure 2. Global Topical Contraceptive Sales Market Share by Type in 2021 & 2028
Figure 3. Topical Contraceptive Suppository Product Picture
Figure 4. Topical Contraceptive Film Product Picture
Figure 5. Topical Contraceptive Pill Product Picture
Figure 6. Others Product Picture
Figure 7. Global Topical Contraceptive Sales Market Share by Application in 2021 & 2028
Figure 8. Online Stores Use Case
Figure 9. Retail Stores Use Case
Figure 10. Topical Contraceptive Report Years Considered
Figure 11. Global Topical Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Topical Contraceptive Market Size 2017-2028 (US$ Million)
Figure 13. Global Topical Contraceptive Sales (2017-2022) & (K Units)
Figure 14. Global Topical Contraceptive Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Topical Contraceptive Sales Market Share by Region (2017-2022)
Figure 16. Global Topical Contraceptive Sales Market Share by Region in 2021
Figure 17. Global Topical Contraceptive Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Topical Contraceptive Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Topical Contraceptive Sales in 2021
Figure 20. Topical Contraceptive Revenue Share by Manufacturers in 2021
Figure 21. Topical Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Topical Cont
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs